Industry Standard Research Identifies Quality CROs
Industry Standard Research (ISR) announced the availability of its 3rd annual CRO Quality Benchmarking Report. The 2011 version of the report profiles 169 pharmaceutical and biotechnology professionals and their experiences with dozens of small, mid-size, and large CROs. In total, data were collected on over 410 Sponsor/CRO interactions.
“We’re operating in an extraordinarily busy and complicated time in the world of drug development,” stated Kevin Olson, CEO, Industry Standard Research. Olson went on: “Drug companies are merging, acquiring, and cutting at seemingly unprecedented rates and outsourcing more and more of their development activities. CROs, for their part, are consolidating at least as fast and need to do everything possible to ensure they stay focused on the quality of their service amidst all the activity. This report provides sponsor companies a critical tool that will maximize their chances of success when selecting a CRO partner. Historically, sponsors have been left to select their CROs based solely on their own experiences and on what the CROs tell them. This “Consumer Reports-style” analysis allows every buyer access to the experience of nearly 200 other drug development professionals worldwide.”
The study, in its third consecutive year of publication, segments much of its data by clinical phase of development. In addition to the annual service quality measurements the study also delivers a detailed analysis of CRO selection drivers, outsourcing volume, preferred CROs, intended future use of specific CROs, and much more. The report contains nearly 300 pages with several hundred charts, graphs, and analysis.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
